News
Herceptin (trastuzumab) is a prescription drug that’s used to treat certain types of breast cancer and stomach cancer. Herceptin can cause side effects that range from mild to serious.
The National Agency for Food and Drug Administration and Control (NAFDAC) has raised a public health alert over the circulation ...
The cancer drug Herceptin saved the author’s life. It also cost $60,000. Would health-care reform put it, and other expensive new drugs, out of reach?
The drug Herceptin is effective in prolonging lives of women whose cancer is HER2-positive. Half got standard treatment, which is given over the course of 12 months.
By 2022 they had developed one that linked Herceptin to another cancer-killing drug. This therapy, for the first time, could damage tumors that had vanishingly low levels of HER2.
Herceptin’s average sales price (ASP) declined 21% between second-quarter 2019 and second-quarter 2022. The five biosimilar entrants not only entered with lower price points, but within three years, ...
Meanwhile, Roche, the Swiss makers of the drug said that they had read The Lancet article, but did not agree with it. The journal said that Herceptin caused heart failure in the women who used it.
Herceptin Infusion 440mg/50ml - 1vial Injection (Trastuzumab) drug information. Find its price or cost, dose, when to use, how to use, side effects, adverse effects, substitutes . It is ...
SAN ANTONIO — Fam-trastuzumab deruxtecan-nxki improved outcomes compared with capecitabine-based regimens as third-line treatment for certain patients with HER2-positive metastatic breast cancer ...
Targeted Therapy: Herceptin. Trastuzumab (Herceptin) was the first targeted therapy approved by the FDA for HER2+ breast cancer. It’s a type of biologic drug called a monoclonal antibody.
Herceptin’s US sales were just over $2.9 billion last year, ... But as they are biologic drugs manufactured in cells there may be some slight differences compared with the reference product.
Trastuzumab and pertuzumab are 2 cancer drugs given together. It’s used to treat early, locally advanced and secondary breast cancer that is HER2 positive. You pronounce trastuzumab as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results